1. Shining light on neurosurgery diagnostics using Raman spectroscopy

   • Brandy Broadbent
   • James Tseng
   • Gregory W. Auner

   Topic Review 13 August 2016 Pages: 1 - 9

   

2. Prognostic role of microRNA-21 expression in gliomas: a meta-analysis

   • Chao Li
   • Jianjun Sun
   • Yimin Cui

   Topic Review 16 August 2016 Pages: 11 - 17

   

3. Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)

   • Anna Sophie Berghoff
   • Gerda Ricken
   • Matthias Preusser

   Laboratory Investigation 19 July 2016 Pages: 19 - 29

   

4. Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying)

   • Quinn T. Ostrom
   • Haley Gittleman
   • Jill S. Barnholtz-Sloan

   Laboratory Investigation 14 July 2016 Pages: 31 - 42

   

5. The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression

   • Anna Joy
   • Manisha Kapoor
   • Burt G. Feuerstein

   Laboratory Investigation 15 July 2016 Pages: 43 - 52

   

6. Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting

   • Sune Munthe
   • Mia D. Sørensen
   • Bjarne Winther Kristensen

   Laboratory Investigation Open access 10 August 2016 Pages: 53 - 62

   

7. ATRX loss in glioneuronal tumors with neuropil-like islands indicates similarity to diffuse astrocytic tumors

   • Aanchal Kakkar
   • Aruna Nambirajan
   • Mehar Chand Sharma

   Laboratory Investigation 28 July 2016 Pages: 63 - 68

   

8. Altered tryptophan metabolism in human meningioma

   • Noble Kumar Talari
   • Manas Panigrahi
   • Prakash Babu Phanithi

   Laboratory Investigation 29 July 2016 Pages: 69 - 77

   

9. hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas

   • Gina Fürtjes
   • Michaela Köchling
   • Benjamin Brokinkel

   Laboratory Investigation 27 July 2016 Pages: 79 - 87

   

10. Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo

    • Tae Jin Han
    • Bong Jun Cho
    • In Ah Kim

    Laboratory Investigation 10 August 2016 Pages: 89 - 98

    

11. RalA is overactivated in medulloblastoma

    • Kevin F. Ginn
    • Ben Fangman
    • Faris Farassati

    Laboratory Investigation 26 August 2016 Pages: 99 - 110

    

12. ZEB1 expression is increased in IDH1-mutant lower-grade gliomas

    • Cody L. Nesvick
    • Chao Zhang
    • Zhengping Zhuang

    Laboratory Investigation 27 August 2016 Pages: 111 - 122

    

13. Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III

    • B. Suchorska
    • C. Hamisch
    • J. Voges

    Clinical Study 15 July 2016 Pages: 123 - 131

    

14. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database

    • Kelly M. Lucchesi
    • Ryan Grant
    • Michael L. DiLuna

    Clinical Study 16 July 2016 Pages: 133 - 140

    

15. Treatment of pediatric cerebral radiation necrosis: a systematic review

    • N. Drezner
    • K. K. Hardy
    • E. I. Hwang

    Clinical Study 20 July 2016 Pages: 141 - 148

    

16. Postoperative surveillance of pediatric cerebellar pilocytic astrocytoma

    • Raphael Alford
    • Lynn Gargan
    • Korgun Koral

    Clinical Study 09 August 2016 Pages: 149 - 154

    

17. Predictive model for recovery of visual field after surgery of pituitary adenoma

    • Junwon Lee
    • Seung Woo Kim
    • Suk Ho Byeon

    Clinical Study 30 July 2016 Pages: 155 - 164

    

18. Proton beam therapy with concurrent chemotherapy for glioblastoma multiforme: comparison of nimustine hydrochloride and temozolomide

    • Masashi Mizumoto
    • Tetsuya Yamamoto
    • Koji Tsuboi

    Clinical Study 17 August 2016 Pages: 165 - 170

    

19. Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

    • Sarah J. Nelson
    • Yan Li
    • Susan M. Chang

    Clinical Study Open access 17 August 2016 Pages: 171 - 179

    

20. Do perfusion and diffusion MRI predict glioblastoma relapse sites following chemoradiation?

    • Jonathan Khalifa
    • Fatima Tensaouti
    • Anne Laprie

    Clinical Study 08 August 2016 Pages: 181 - 192

    

21. Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastoma

    • D. Jay McCracken
    • Emma C. Celano
    • Jeffrey J. Olson

    Clinical Study 09 August 2016 Pages: 193 - 201

    

22. White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study

    • Benjamin-Andreas Berk
    • Sandra Nagel
    • Clemens Seidel

    Clinical Study 17 August 2016 Pages: 203 - 209

    

23. Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients

    • Deborah T. Blumenthal
    • Addie Dvir
    • Felix Bokstein

    Clinical Study 16 August 2016 Pages: 211 - 219

    

24. Impact of resection and systemic therapy on the survival of patients with brain metastasis of metastatic renal cell carcinoma

    • YueJun Du
    • Sascha Pahernik
    • Carsten Grüllich

    Clinical Study 18 August 2016 Pages: 221 - 228

    

25. MR imaging features that distinguish spinal cavernous angioma from hemorrhagic ependymoma and serial MRI changes in cavernous angioma

    • Inhwan Jeon
    • Woo Sang Jung
    • Sung Jun Ahn

    Clinical Study 16 August 2016 Pages: 229 - 236

    

26. Deciphering the real incidence of medulloblastoma with extensive nodularity in adult patients

    • Marco Gessi
    • Torsten Pietsch

    Letter to the Editor 13 July 2016 Pages: 237 - 238

27. Challenges in epilepsy-associated tumors

    • Marco Giulioni
    • Matteo Martinoni
    • Gianluca Marucci

    Letter to the Editor 06 August 2016 Pages: 239 - 240